Hines JB, Cameron RB, Esposito A, Kim L, et al. Evaluation of MPR and pCR as surrogate endpoints for survival in randomized controlled trials of neoadjuvant immune checkpoint blockade in resectable in non-small cell lung cancer. J Thorac Oncol 2024 Mar 8:S1556-0864(24)00117.
PMID: 38461929